Category - Pharma Industry News
Enhertu improves progression-free survival in breast cancer trial
US approval for Sanofi’s late-onset Pompe disease med Nexviazyme
Interim trial data for UCB’s bimekizumab shows positive results
AZ’s Forxiga gains EC, MHRA approvals for chronic kidney disease
mRNA takes off
More positive results for Sanofi, Regeneron’s Libtayo
UK watchdog: Pfizer and Flynn Pharma overcharged NHS
Kite and Appia Bio to collaborate on allogenic cell therapies for cancer